Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Apr
16
2024
This Week in 340B: April 9 – April 15, 2024 McDermott Will & Emery
Apr
16
2024
Navigating Health Tech: Regulations for AI/ML in Medical Devices and Software [Video] Mintz
Apr
16
2024
BRight Minds in Healthcare Delivery Episode 5: Structuring and Maintaining Value-based Care Arrangements [Podcasts] Blank Rome LLP
Apr
16
2024
Environmental Developments to Watch in California in 2024 Beveridge & Diamond PC
Apr
16
2024
FDA Releases Data on EMA Honey Keller and Heckman LLP
Apr
15
2024
Preparing for Michigan Liquor License Renewal 2024-2025 Varnum LLP
Apr
15
2024
What Food & Beverage Companies Need to Know About the U.S. Consumer Product Safety Commission Foley & Lardner LLP
Apr
15
2024
U.S. Environmental Protection Agency Finalizes National Primary Drinking Water Regulations for Certain PFAS Chemicals Babst, Calland, Clements & Zomnir, P.C.
Apr
15
2024
A Win for the SEC on Shadow Trading. Now What? ArentFox Schiff LLP
Apr
15
2024
Preparing for Evolving Cybersecurity Threats McDermott Will & Emery
Apr
15
2024
No Can Do for Mo Cann Do: Missouri Supreme Court Upholds Denial of Cannabis License to Applicant with Insufficient Paperwork Bradley Arant Boult Cummings LLP
Apr
15
2024
Chlormequat Contamination in Food Products Draws Attention K&L Gates
Apr
12
2024
ARS Researchers Discover Ability of Cotton Gin Waste to Transform Silver Ions into Silver Nanoparticles Bergeson & Campbell, P.C.
Apr
12
2024
McDermottPlus Check-Up: April 12, 2024 McDermott Will & Emery
Apr
12
2024
340B Remedy Rule and Medicare Advantage Rates: Navigating Shifting Payments McDermott Will & Emery
Apr
11
2024
FDA Releases Draft Guidance on New Dietary Ingredient Notification Master Files for Dietary Supplements Epstein Becker & Green, P.C.
Apr
11
2024
ITU Applicants Beware: Federal Courts Have Jurisdiction Over Pending Trademark Applications McDermott Will & Emery
Apr
11
2024
Kratom Chronicles: Maryland Steps Up Herbal Saga, Other States Leafing Through Their Laws Norris McLaughlin P.A.
Apr
11
2024
China Semiconductor Export Regulations, Episode V – Updates and Corrections to the Advanced Computing and Semiconductor Regulations Sheppard, Mullin, Richter & Hampton LLP
Apr
10
2024
Floridians to Decide Fate of Adult-Use Marijuana This November Bradley Arant Boult Cummings LLP
Apr
9
2024
This Week in 340B: April 2 – April 8, 2024 McDermott Will & Emery
Apr
9
2024
FDA Reports That No Asbestos Was Detected in Its 2023 Testing of Talc-Containing Cosmetic Products Bergeson & Campbell, P.C.
Apr
9
2024
PBM Policy and Legislative Update — Winter 2024 Mintz
Apr
9
2024
California Greatly Expands List of Cosmetics Fragrances Reportable as Allergens ArentFox Schiff LLP
Apr
9
2024
The Italian DPA Has Its Eyes on Biometric IDs – Another Fight on Tech or a Win for Privacy? Squire Patton Boggs (US) LLP
Apr
8
2024
FDA Publishes Draft Guidance on NDIN Master Files Keller and Heckman LLP
Apr
8
2024
Will Hemp Save the World, Before the Government Kills It? Bradley Arant Boult Cummings LLP
Apr
8
2024
While You Were Sleeping – Development of the Hydrogen Hubs Keeps On Rolling Barnes & Thornburg LLP
Apr
6
2024
EPA Proposes to Require Submission of Health and Safety Studies for 16 Chemicals Being Considered for TSCA Risk Evaluation Bergeson & Campbell, P.C.
Apr
5
2024
Pharmaceutical Companies May Be the First Targets of the Washington State My Health My Data Act Greenberg Traurig, LLP
Apr
5
2024
New York Cannabis Regulations Are (Initially Ruled) Unconstitutional, Says New York Judge ArentFox Schiff LLP
Apr
4
2024
Proposal to Revamp Alabama Medical Cannabis Program Met with Near-Unanimous Opposition Bradley Arant Boult Cummings LLP
Apr
4
2024
Cancer Drugs (Antibody Drug Conjugates): An FDA Perspective Foley & Lardner LLP
Apr
4
2024
FDA Reminds Stakeholders of Animal Drug ‘Approved by FDA’ Labeling Requirements Greenberg Traurig, LLP
Apr
4
2024
Take the Beer Goggles Off: Ambiguity Prevents Summary Judgment McDermott Will & Emery
Apr
4
2024
CTP Releases New 5-year Strategic Plan Keller and Heckman LLP
Apr
4
2024
AMS Requests Information to Update List of Bioengineered Foods Bergeson & Campbell, P.C.
Apr
3
2024
FTC’s Campaign Against Improper Orange Book Listings Continues with Amicus Brief in Teva’s Challenge of Amneal Asthma Inhaler ANDA Sheppard, Mullin, Richter & Hampton LLP
Apr
3
2024
EPA Describes Future of Its Nanotechnology Research Bergeson & Campbell, P.C.
Apr
3
2024
FDA Warning Letter Is a Stark Reminder that if You Claim Your Product Is RUO, it Has to Be RUO Mintz
Apr
3
2024
US FDA to Develop Regulatory Scheme for AI in Medical Products, Foster International Cooperation Greenberg Traurig, LLP
Apr
3
2024
The “Fix” Is In: Alabama Legislature to Consider Controversial Proposal to Revamp Stalled Medical Cannabis Program Bradley Arant Boult Cummings LLP
Apr
3
2024
FDA Revokes Standard of Identity for Frozen Cherry Pie Keller and Heckman LLP
Apr
3
2024
This Week in 340B: March 19 – 25, 2024 McDermott Will & Emery
Apr
3
2024
This Week in 340B: March 13 – 18, 2024 McDermott Will & Emery
Apr
3
2024
New Florida Third-Party Food Delivery Law in Effect Greenberg Traurig, LLP
Apr
3
2024
This Week in 340B: March 26 – April 1, 2024 McDermott Will & Emery
Apr
2
2024
NIOSH Science Blog Item Highlights 20 Years of NTRC’s Field Studies Team Bergeson & Campbell, P.C.
Apr
2
2024
Litigation Minute: Class-Action Challenges to Natural and Clean Beauty Product Claims K&L Gates
Apr
2
2024
Unpacking Averages: Adverse Events for Device-Lead Combination Products Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins